|
|||||
|
|
Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus |
|
| Authors: | Richard Furie William Stohl Ellen M Ginzler Michael Becker Nilamadhab Mishra Winn Chatham Joan T Merrill Arthur Weinstein W Joseph McCune John Zhong Wendy Cai William Freimuth |
| Affiliation: | Division of Rheumatology and Allergy-Clinical Immunology, North Shore Long Island Jewish Health System, Marcus Avenue, Lake Success, New York 11042, USA. furie@nshs.edu |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed SpringerLink 等数据库收录！ | |